Chicago, Illinois
United States
26
2025-02-20
26
2026-01-13
These are the the leading inventors for applications assigned to Tempus AI, Inc.:
Tempus AI, Inc. based in Chicago, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
SYSTEMS AND METHODS OF RADIOMICS BASED CANCER STRATIFICATION
#2 | 2024-12-26 β Patent 12,412,665 granted on 2025-09-09METHODS FOR EVALUATING THE EFFECT OF THE START DATE FOR CANCER TREATMENT WITH A CANCER MEDICATION USING PROPENSITY SCORING
#3 | 2024-12-05 β Patent 12,525,343 granted on 2026-01-13ARTIFICIALLY INTELLIGENT ROUTING AGENT FOR ROUTING PORTIONS OF A TASK THROUGH MULTIPLE CUSTOMIZED AGENTS, AND SYSTEMS, DEVICES, AND METHODS OF USE THEREOF
#4 | 2024-08-08 β Patent 12,512,187 granted on 2025-12-30SPARSE N-GRAM MODELING FOR PATIENT-ENTITY RELATION EXTRACTION
#5 | 2024-05-16 β Patent 12,586,391 granted on 2026-03-24Systems and Methods for Deconvolving Cell Types in Histology Slide Images, Using Super-Resolution Spatial Transcriptomics Data
#6 | 2023-10-26 β Patent 12,190,884 granted on 2025-01-07Collaborative artificial intelligence method and system
#7 | 2023-10-19 β Patent 12,062,372 granted on 2024-08-13Collaborative artificial intelligence method and system
#8 | 2023-10-12 β Patent 12,203,139 granted on 2025-01-21Systems and methods for detecting multi-molecule biomarkers
#9 | 2023-08-24 β Patent 12,536,595 granted on 2026-01-27MOBILE SUPPLEMENTATION, EXTRACTION, AND ANALYSIS OF HEALTH RECORDS
#10 | 2023-07-13 β Patent 12,112,839 granted on 2024-10-08Data based cancer research and treatment systems and methods
#11 | 2023-04-20 β Patent 12,129,519 granted on 2024-10-29TCR/BCR profiling using enrichment with pools of capture probes
#12 | 2023-02-02 β Patent 12,663,414 granted on 2026-06-23Platform For Co-Culture Imaging To Characterize In Vitro Efficacy Of Heterotypic Effector Cellular Therapies In Cancer
#13 | 2022-12-22 β Patent 12,524,826 granted on 2026-01-13DETERMINING BIOMARKERS FROM HISTOPATHOLOGY SLIDE IMAGES
#14 | 2022-12-08 β Patent 12,451,250 granted on 2025-10-21SYSTEMS AND METHODS FOR PREDICTING THERAPEUTIC SENSITIVITY
#15 | 2022-10-06 β Patent 12,119,103 granted on 2024-10-15GANs for latent space visualizations
#16 | 2022-10-06 β Patent 12,165,753 granted on 2024-12-10Systems and methods for interrogating clinical documents for characteristic data
#17 | 2022-09-15 β Patent 12,165,236 granted on 2024-12-10Predicting total nucleic acid yield and dissection boundaries for histology slides
#18 | 2022-09-15 β Patent 12,361,542 granted on 2025-07-15SYSTEMS AND METHODS FOR DEEP ORTHOGONAL FUSION FOR MULTIMODAL PROGNOSTIC BIOMARKER DISCOVERY
#19 | 2022-08-18 β Patent 12,271,832 granted on 2025-04-08Artificial intelligence engine for directed hypothesis generation and ranking
#20 | 2022-05-19 β Patent 12,618,115 granted on 2026-05-05DETERMINATION OF CYTOTOXIC GENE SIGNATURE AND ASSOCIATED SYSTEMS AND METHODS FOR RESPONSE PREDICTION AND TREATMENT
#21 | 2022-02-17 β Patent 12,217,429 granted on 2025-02-043D radiomic platform for imaging biomarker development
#22 | 2021-09-02 β Patent 12,365,943 granted on 2025-07-22SYSTEMS AND METHODS FOR NEXT GENERATION SEQUENCING UNIFORM PROBE DESIGN
#23 | 2021-08-12 β Patent 12,584,176 granted on 2026-03-24INTEGRATED MACHINE-LEARNING FRAMEWORK TO ESTIMATE HOMOLOGOUS RECOMBINATION DEFICIENCY
#24 | 2021-07-08 β Patent 12,462,911 granted on 2025-11-04CLINICAL CONCEPT IDENTIFICATION, EXTRACTION, AND PREDICTION SYSTEM AND RELATED METHODS
#25 | 2021-04-22 β Patent 12,603,150 granted on 2026-04-14CALCULATING CELL-TYPE RNA PROFILES FOR DIAGNOSIS AND TREATMENT
#26 | 2021-03-18 β Patent 12,471,827 granted on 2025-11-18ECG BASED FUTURE ATRIAL FIBRILLATION PREDICTOR SYSTEMS AND METHODS
Also check out Tempus AI, Inc.'s (Chicago, United States) applicant profile with 80 patent applications submitted.
622164 β